Intelligence / Healthtech / New Clinical Trials / HALEON
Clinicaltrial registered2 Nov 2026
HALEON
2 Nov 2026: Trial registered · A Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily Functioning. Recorded in the ClinicalTrials.gov (US National Library of Medicine).
- Posted
- 2 Nov 2026
- Title
- A Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily Functioning
- Conditions
- Pain
- Study Type
- Observational
- Status
- Not Yet Recruiting
- Countries
- Singapore
- Country
- Singapore
- Reference
- NCT07909590
- Location
- Singapore
What this signal means
A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at HALEON
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.
Across AOS Research
Other records for HALEON in our registers.
More from Singapore
New Clinical Trials
17 NovAstraZenecatrial registered · A Study to Investigate the Efficacy and Safety of Dato-DXd-based Combinations in Participants With TROP2 NMR+ NSCLCClinical13 NovEli Lilly and Companytrial registered · A Study Assessing Eloralintide (LY3841136) in Healthy ParticipantsClinical12 NovHALEONtrial registered · A Retrospective Study to Assess Patient-Reported Treatment Experience With Over-the-Counter Analgesic ProductsClinical5 NovCutis Medical Laser Clinics Pte Ltdtrial registered · Effectiveness of Sequential Monopolar and Bipolar Radiofrequency Device for Facial Rejuvenation in Female ParticipantsClinical4 NovBoehringer Ingelheimtrial registered · A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Clinical4 NovEli Lilly and Companytrial registered · A Study of Lepodisiran (LY3819469) in Participants With High Lipoprotein(a)Clinical
Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.